Helicobacter hepaticus Cholesterol-α-glucosyltransferase is Essential for Establishing Colonization in Male A/JCr Mice

Helicobacter

Volumn 19, Issue 4, 2014, Pages 280-288

  Ge, Zhongming ^a   Feng, Yan ^a   Muthupalani, Sureshkumar ^a   Whary, Mark T ^a   Versalovic, James ^b   Fox, James G ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bacterial load; Cholesterol; Helicobacter hepaticus; Model; Mouse; Virulence genes

Indexed keywords

CHOLESTEROL ALPHA GLUCOSYLTRANSFERASE; GAMMA INTERFERON; GLUCOSYLTRANSFERASE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; RNA; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CHOLESTEROL; CYTOKINE; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BIFIDOBACTERIUM BIFIDUM; CECUM; CLOSTRIDIUM; CLOSTRIDIUM METHHYLPENTOSUM; CLOSTRIDIUM THERMOCELLUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HELICOBACTER BILIS; HELICOBACTER HEPATICUS; HELICOBACTER INFECTION; HELICOBACTER MUSTELAE; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; INFECTIOUS HEPATITIS; INTESTINE; LACTOBACILLUS ACIDOPHILUS; LIVER; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TH1 CELL; TH2 CELL; TREPONEMA; TREPONEMA AZOTONUTRICIUM; TREPONEMA BRENNABORENESE; WILD TYPE; A J MOUSE; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; ENZYMOLOGY; GENE DELETION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CECUM; CHOLESTEROL; CYTOKINES; DISEASE MODELS, ANIMAL; GENE DELETION; GLUCOSYLTRANSFERASES; HELICOBACTER HEPATICUS; HELICOBACTER INFECTIONS; LIVER; MALE; MICE, INBRED A; REAL-TIME POLYMERASE CHAIN REACTION; VIRULENCE FACTORS;

EID: 84904668488     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12135     Document Type: Article

References (30)

1. Hirai Y, Haque M, Yoshida T, Yokota K, Yasuda T, Oguma K. Unique cholesteryl glucosides in Helicobacter pylori: composition and structural analysis. J Bacteriol 1995;177:5327-33.
2. Lee H, Kobayashi M, Wang P, Nakayama J, Seeberger PH, Fukuda M. Expression cloning of cholesterol alpha-glucosyltransferase, a unique enzyme that can be inhibited by natural antibiotic gastric mucin O-glycans, from Helicobacter pylori. Biochem Biophys Res Commun 2006;349:1235-41.
3. Wunder C, Churin Y, Winau F, Warnecke D, Vieth M, Lindner B, Zahringer U, Mollenkopf HJ, Heinz E, Meyer TF. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med 2006;12:1030-8.
4. McGee DJ, George AE, Trainor EA, Horton KE, Hildebrandt E, Testerman TL. Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37. Antimicrob Agents Chemother 2011;55:2897-904.
5. Rogers AB, Fox JG. Inflammation and Cancer. I. Rodent models of infectious gastrointestinal and liver cancer. Am J Physiol Gastrointest Liver Physiol 2004;286:G361-6.
6. Fox JG, Ge Z, Whary MT, Erdman SE, Horwitz BH. Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer. Mucosal Immunol 2011;4:22-30.
7. Kobayashi T, Harada K, Miwa K, Nakanuma Y. Helicobacter genus DNA fragments are commonly detectable in bile from patients with extrahepatic biliary diseases and associated with their pathogenesis. Dig Dis Sci 2005;50:862-7.
8. Hamada T, Yokota K, Ayada K, Hirai K, Kamada T, Haruma K, Chayama K, Oguma K. Detection of Helicobacter hepaticus in human bile samples of patients with biliary disease. Helicobacter 2009;14:545-51.
9. Suerbaum S, Josenhans C, Sterzenbach T, et al. The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc Natl Acad Sci USA 2003;100:7901-6.
10. Fox JG, Dewhirst FE, Tully JG, Paster BJ, Yan L, Taylor NS, Collins MJ Jr, Gorelick PL, Ward JM. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol 1994;32:1238-45.
11. Ge Z, Lee A, Whary MT, Rogers AB, Maurer KJ, Taylor NS, Schauer DB, Fox JG. Helicobacter hepaticus urease is not required for intestinal colonization but promotes hepatic inflammation in male A/JCr mice. Microb Pathog 2008;45:18-24.
12. Ge Z, Feng Y, Whary MT, Nambiar PR, Xu S, Ng V, Taylor NS, Fox JG. Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice. Infect Immun 2005;73:3559-67.
13. Rogers AB, Boutin SR, Whary MT, Sundina N, Ge Z, Cormier K, Fox JG. Progression of chronic hepatitis and preneoplasia in Helicobacter hepaticus-infected A/JCr mice. Toxicol Pathol 2004;32:668-77.
14. Ge Z, White DA, Whary MT, Fox JG. Fluorogenic PCR-based quantitative detection of a murine pathogen Helicobacter hepaticus. J Clin Microbiol 2001;39:2598-602.
15. Whary MT, Morgan TJ, Dangler CA, Gaudes KJ, Taylor NS, Fox JG. Chronic active hepatitis induced by Helicobacter hepaticus in the A/JCr mouse is associated with a Th1 cell-mediated immune response. Infect Immun 1998;66:3142-8.
16. Fox JG, Li X, Yan L, Cahill RJ, Hurley R, Lewis R, Murphy JC. Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis. Infect Immun 1996;64:1548-58.
17. Ge Z, Rogers AB, Feng Y, Lee A, Xu S, Taylor NS, Fox JG. Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell Microbiol 2007;9:2070-80.
18. Solnick JV, Schauer DB. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin Microbiol Rev 2001;14:59-97.
19. Berg RD. Bacterial translocation from the gastrointestinal tract. Trends Microbiol 1995;3:149-54.
20. Yeagle PL. Modulation of membrane function by cholesterol. Biochimie 1991;73:1303-10.
21. Incardona JP, Eaton S. Cholesterol in signal transduction. Curr Opin Cell Biol 2000;12:193-203.
22. Beigier-Bompadre M, Moos V, Belogolova E, Allers K, Schneider T, Churin Y, Ignatius R, Meyer TF, Aebischer T. Modulation of the CD4 + T-cell response by Helicobacter pylori depends on known virulence factors and bacterial cholesterol and cholesterol alpha-glucoside content. J Infect Dis 2011;204:1339-48.
23. Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, Kasama S, Fukuda MN, Fukuda M, Katsuyama T, Nakayama J. Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science 2004;305:1003-6.
24. Dietschy JM, Gamel WG. Cholesterol synthesis in the intestine of man: regional differences and control mechanisms. J Clin Invest 1971;50:872-80.
25. Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology 2009;136:1863-73.
26. Amedei A, Codolo G, Del Prete G, de Bernard M, D'Elios MM. The effect of Helicobacter pylori on asthma and allergy. J Asthma Allergy 2010;3:139-47.
27. Codolo G, Mazzi P, Amedei A, Del Prete G, Berton G, D'Elios MM, de Bernard M. The neutrophil-activating protein of Helicobacter pylori down-modulates Th2 inflammation in ovalbumin-induced allergic asthma. Cell Microbiol 2008;10:2355-63.
28. Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C, Muller A. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 2011;121:3088-93.
29. Oertli M, Sundquist M, Hitzler I, et al. DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest 2012;122:1082-96.
30. Chang YJ, Kim HY, Albacker LA, et al. Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. J Clin Invest 2011;121:57-69.